Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma
Authors:
- Pierluigi Benedetti PaniciPPPierluigi Benedetti Panici
- Stefano BasileSBStefano Basile
- Violante Di DonatoVDViolante Di Donato
- Claudia MarchettiCMClaudia Marchetti
- Giorgia PerniolaGPGiorgia Perniola
- Francesco ManeschiFMFrancesco Maneschi
- Andrea Alberto LissoniALAndrea Alberto Lissoni
- Mauro SignorelliMSMauro Signorelli
- 1 April 2014
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 210 (4) , 363.e1-363.e10
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Recent changes in endometrial cancer trends among menopausal-age US womenCancer Epidemiology, 2013
- Impact of weight change and weight cycling on risk of different subtypes of endometrial cancerEuropean Journal of Cancer, 2013
- Lymphadenectomy in endometrial cancer: what's the right question?American Journal of Obstetrics and Gynecology, 2012
- Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluationGynecologic Oncology, 2012
- Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?Gynecologic Oncology, 2011
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992–2002Gynecologic Oncology, 2008
- The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiationGynecologic Oncology, 2006
- Is endometrial carcinoma intrinsically more aggressive in elderly patients?Cancer, 2003
- Age as a Prognostic Factor for Recurrence in Patients with Endometrial CarcinomaGynecologic Oncology, 2000